234 related articles for article (PubMed ID: 31549859)
1. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
2. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
3. Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.
Cai C; Zhang Y; Peng X
Bioengineered; 2021 Dec; 12(2):9390-9400. PubMed ID: 34823420
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
5. Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis.
Gao F; Wang D; Liu X; Wu YH; Wang HT; Sun SL
Arch Biochem Biophys; 2022 Sep; 727():109323. PubMed ID: 35714697
[TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
7. Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211.
Zhang H; Ding S; Xia L
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33245099
[TBL] [Abstract][Full Text] [Related]
8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA
Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
[TBL] [Abstract][Full Text] [Related]
10. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
11. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
12. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
[TBL] [Abstract][Full Text] [Related]
13. Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
Liu T; Liu P; Ding F; Yu N; Li S; Wang S; Zhang X; Sun X; Chen Y; Wang F; Zhao Y; Li B
Oncol Rep; 2015 Feb; 33(2):861-7. PubMed ID: 25502786
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
Rosso M; Majem B; Devis L; Lapyckyj L; Besso MJ; Llauradó M; Abascal MF; Matos ML; Lanau L; Castellví J; Sánchez JL; Pérez Benavente A; Gil-Moreno A; Reventós J; Santamaria Margalef A; Rigau M; Vazquez-Levin MH
PLoS One; 2017; 12(9):e0184439. PubMed ID: 28934230
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
[TBL] [Abstract][Full Text] [Related]
16. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract][Full Text] [Related]
17. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
Zuo P; Ma Y; Huang Y; Ye F; Wang P; Wang X; Zhou C; Lu W; Kong B; Xie X
Gynecol Oncol; 2014 Mar; 132(3):745-51. PubMed ID: 24486602
[TBL] [Abstract][Full Text] [Related]
18. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
20. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
